CTOs on the Move


 
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers. Collaborating with some of the world`s largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.corium.com
  • 4558, 50th Street Southeast
    Kentwood, MI USA 49512
  • Phone: 616.656.4563

Executives

Name Title Contact Details
Niraj Vasisht
Chief Technology Officer Profile

Similar Companies

Paramount Pharmacies Limited

Paramount Pharmacies Limited is a New Waterford, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wilkinson Pharmacy

Wilkinson Pharmacy is a Nevada, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Standard Bariatrics

Cincinnati-based surgical procedure company focused on innovative development, commercialization of medical devices for treatment of obesity, gastrectomy.

Summers Laboratories

Summers Laboratories Inc. is a Collegeville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Navidea

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) is a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics. Navidea is developing multiple precision-targeted products based on its Manoceptâ„¢ platform to enhance patient care by identifying the sites and pathways of disease and enable better diagnostic accuracy, clinical decision-making, and targeted treatment. Navidea`s Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on activated macrophages. The Manocept platform serves as the molecular backbone of Tc99m tilmanocept, the first product developed and commercialized by Navidea based on the platform. Navidea`s strategy is to deliver superior growth and shareholder return by bringing to market novel products and advancing the Company`s pipeline through global partnering and commercialization efforts.